Vyvanse (lisdexamfetamine dimesylate) was approved by the U.S. Food and Drug Administration (FDA) on Friday as the first medication permitted to treat binge-eating disorder in adults. Read More »

The Biotechnology Industry Organization (BIO) applauded President Barack Obama’s launch of the Precision Medicine Initiative during his State of the Union address on Jan. 20. Read More »

The U.S. Food and Drug Administration (FDA) granted Genentech, a member of the Roche Group, a Breakthrough Therapy Designation for its cancer immunotherapy trial MPDL3280A (anti-PDL1). Read More »

The U.S. Food and Drug Administration (FDA) approved PREZCOBIX™ (darunavir /cobicistat) tablets for the treatment of human immunodeficiency virus (HIV-1), Janssen Therapeutics, Division of Janssen Products, LP (Janssen) announced on Jan. 29. Read More »

Savaysa (edoxaban) has been approved by the Food and Drug Administration to reduce the risk of stroke and blood clots in patients with atrial fibrillation not caused by a heart valve problem. Read More »

The U.S. Food and Drug Administration (FDA) recently approved the drug Natpara, manufactured by NPS Pharaceuticals, Inc., to treat low blood calcium levels in patients with hypoparathyroidism. Read More »

The U.S. Food and Drug Administration (FDA) recently approved the Maestro Rechargeable System, a unique treatment for obesity that is surgically implanted and targets the nerves between the brain and the stomach. Read More »

The U.S. Food and Drug Administration (FDA) approved generic Lamictal (lamotrigine) Orally Disintegrating Tablets (Lamictal ODT) this week, clearing the way for Impax Laboratories, Inc. to start marketing the antiepileptic drug to consumers. Read More »

Pharmacy benefit manager Prime Therapeutics, LLC recently agreed to place Gilead Sciences' Harvoni and AbbVie's Viekira Pak on its preferred drug list for hepatitis C patients. Read More »